|
|
||||||||
|
|
|||||||||
|
|
Radiopharmaceutical Chemistry: New Chemistry-OncologyNew Chemistry-Oncology Posters |
1 Exp Diag Imaging, UTMD Anderson Cancer Ctr, Houston, Texas
1258
Objectives: This study was aimed to synthesize 68Ga-1, 4, 8, 11-tetraazacyclotetradecane-
-methyl-D, L-tyrosine (68Ga-N4-AMT) as apotential radiotracer for imaging lung and breast tumors.
Methods: The phenolic hydroxy group of N-t-butoxycarbonyl (BOC) AMT ethyl ester was reacted with bromopropanol, followed by tosylation to afford N-BOC-O-3-tosylpropyl-AMT ethyl ester. N4-AMT was synthesized by reacting trifloroacetylated cyclam and N-BOC -O-3-tosylpropyl-AMT, followed by acidic hydrolysis to remove protected N-BOC, trifluoroacetate and ethyl ester. 68GaCL3 was eluted from a 68Ge/68Ga generator (Eckert & Ziegler, Berlin, Germany). N4-AMT (1 mg) was labeled with 68Ga(III) using acetate buffer (pH 5). The lung and breast tumor-bearing models were created by inoculating with NCI-H187 lung tumor cells (106 cells/mouse) and rat 13762 breast tumor cells (105 cells/rat) sc in the right hond limbs of nude mice or F-344 rats, respectively. The rodents were administered with 68Ga-N4, 68Ga-N4-AMT and 18F-FDG (300-500 uCi/rodent, iv). PET imaging was performed on a microPET R4 (Siemens).
Results: N4-AMT was confirmed by NMR and mass spectrometry. Radiochemical purity of 68Ga N4-AMT was > 96 %. The specific activity of 68Ga-N4-AMT was 0.13 Ci/mmol. The lung tumor was clearly visualized by 68Ga N4-AMT but poorly with 18F-FDG or 68Ga-N4 at 45 minutes post-injection. From dynamic scans acquired, tumor-to-muscle uptake ratios were ranged 3 to 8 in a breast tumor-bearing rat from 60 to 90 min.
Conclusions: PET with 68Ga N4-AMT is a promising and sensitive agent for detection of tumors. The cellular kinetic uptake, mechanistic studies and biodistribution of this novel tracer in tumor models are underway.
| ||||||||||||||||||||||||||||||||||||||